CPHI Pharma Index highlights the importance of international partnering
Survey results reveal 84% of the industry is actively searching for new partners.
Ahead of the CPHI Festival of Pharma (5-16 October 2020), the CPHI Pharma Index shows only Italy and India have improved their score in 2020, with the majority of industry executives looking for new supply chain partners.
The Index – an aggregated confidence score across the five main small molecule categories (API production quality, finished dose production quality, growth potential, overall competitiveness, and innovativeness) in each of the largest economies – compiled the findings from more than 550 executives and sees an overall decrease of 0.86% in score across all nations for the first time.
This is perhaps no great surprise given the global impact of COVID-19. Despite this, the Index shows that overall, pharma is in a strong position; globally, the industry has weathered the impact of the pandemic well.
Many leading pharma economies have again scored strongly in ‘innovation’ and ‘pharmaceutical quality’ and the slight fall on 2019 results reflects reduced confidence in growth rather than quality.
The major exception to the overall trend is Italy, which has seen a dramatic increase of nearly 6.3% in overall score, with its API industry widely perceived to be a primary beneficiary of global shifts in ingredient sourcing strategies.
China’s overall score has fallen (5.9%) for the first time, but the report predicts a likely dramatic bounce back in 2021, citing a gradual shift towards a pharma economy led by domestic – not international – sales.
"The scores reflect a very strong industry and a growing industry. The year-on-year score decrease is a reflection of the strength of the 2019 results, and this slight fall still points to very positive outcomes (as scores are high across all categories), particularly in the medium- and long-term,” commented Cara Turner, Brand Director at CPHI Festival of Pharma.
A particularly notable finding from the executive survey is that global pharma executives have shifted focus towards securing increased supply side partners, with 84% of the industry actively searching for new partners.
Interestingly, the starting materials maket remains ambivalent as to whether it would be beneficial to bring these home to domestic markets - 48% of respondents believe domestic production is ‘desirable’.
“What our global pharma surveys show is that the pandemic has increased the importance of finding new international partners and improving supply chain contingencies,” added Turner.
Related News
-
News On Track at CPHI NA 2024: Sustainable Futures with Thermo Fisher Scientific
On the 7-9 May 2024 in Philadelphia, CPHI NA will be presenting an unmissable agenda, filled with content across 4 main tracks. In the following interview the Sustainable Futures Track sponsor, Thermo Fisher Scientific gives an overview of what to expe... -
News LEAP-ing into the future of pharma – the CPHI Middle East Vision
On March 6, 2024, the CPHI team hosted the Future of Pharma Forum at LEAP 2024, Saudi Arabia’s premier destination for tech leaders and innovators to meet and collaborate. -
News CPHI Middle East 2024 – What do we have to look forward to?
We’re bringing CPHI to the Middle East in December 2024. CPHI brings together the pharma community from all over the world, creating a platform for education, collaboration, and progress. -
News CPHI Pharma Awards 2023 – Packaging & Machinery Winner: Gasporox
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October 2023. In this series of interviews, we speak to the people and teams behind the award-winning projects, concepts, and techno... -
News Unpacking what we learnt: Key Pharmapack takeaways with L.E.K. Consulting
After another successful Pharmapack show, we sat down with Karin von Kienlin, Senior Partner at L.E.K. Consulting, to discuss the biggest takeaways and surprises from 2 days of intense discussion and collaboration. -
News Key takeaways from Saudi Arabia's National Biotechnology Strategy
In January 2024, Saudi Arabia released its National Biotech Strategy, an ambitious plan to localise biomanufacturing, incentivise R&D and establish the Kingdom as the regional biotech leader by 2030, and an internationally recognised hub by 2040. -
News Pharmapack Awards 2024 Packaging Innovation Award Winner – Nissha Europe GmbH
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industyr on January 24, 2024. -
News What did we learn from Pharmapack 2024? The green edition
Pharmapack Europe, held in Paris each year is a great opportunity to see the latest innovations and trends in pharmaceutical packaging and to hear from the companies and experts in the area on what aspects are most important to them in their products a...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance